tirzepatide atrial fibrillation Will taking Mounjaro (tirzepatide) worsen (AFib) episodes in a patient with chronic AFib on losartan (angiotensin II receptor antagonist) and sotalol (antiarrhythmic medication)? Tirzepatide (LY3298176) is a Dual

The game is over

Whether your dose increases from 2.5 mg to 15 mg, your monthly cost remains the sameensuring predictable, transparent pricing throughout your weight loss journey

Diabetes Prevention Program Research

The deadline is Headline The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation Headline A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission Blog Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to

A five-year clinical trial is in the works to assess potential risks, but for now, there is no restriction on how long Mounjaro can be prescribed